We use cookies to offer you the best experience on our site. You can find out more about the cookies we use or disable them in the Cookie settings
SensoLyte® 490 HCV Protease Assay Kit Fluorimetric 500 assays - 1 kit
- Cat.Number : AS-71126
- Manufacturer Ref. :
-
Availability :
In production
- Shipping conditions : Ice delivery fees must be applied
Alternative choices
HCV protease is identified as an important drug-screening target. The SensoLyte® 490 HCV Protease Assay Kit uses an optimized FRET peptide substrate for the continuous measurement of HCV NS3/4a activity. This FRET substrate is cleaved specifically by HCV NS3/4a protease thereby liberating the C-terminal peptide-fluorophore fragment from the proximity quenching effect of the dark quencher, resulting in a more than 10-fold increase in fluorescence. This assay can detect HCV NS3/4a protease activity at 1 pmole.
Specifications
Packaging | |
Kits components |
|
---|---|
Properties | |
Absorbance (nm) |
|
Emission (nm) |
|
Storage & stability | |
Storage Conditions |
|
Activity | |
Application | |
Biomarker Target | |
Detection Method | |
Detection Limit |
|
Research Area | |
Sub-category Research Area | |
Usage |
|
Codes | |
Code Nacres |
|
Downloads
You may also be interested in the following product(s)
Citations
2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity.
Bioorg Med Chem Lett . 2011 Jun 01 ; 21(11) 3202 | DOI : 10.1016/j.bmcl.2011.04.055
- H.R. Park
- et al
Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase.
J Infect Dis. . 2011 Aug 15 ; 204(4) 609 | DOI : 10.1093/infdis/jir303
- L.F. Peng
- et al
Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.
Antiviral Res . 2011 Sep 01 ; 91(3) 233 | DOI : 10.1016/j.antiviral.2011.05.017
- C. Yon
- et al
A method to simultaneously monitor hepatitis C virus NS3 helicase and protease activities.
Methods Mol Biol . 2010 Jan 01 ; 587 223 | DOI : 10.1007/978-1-60327-355-8_16
- D.N. Frick
- et al